Cognitive functioning and subjective quality of life in relapsing-remitting multiple sclerosis patients before and after percutaneous transluminal angioplasty: a preliminary report

Código QR

Cognitive functioning and subjective quality of life in relapsing-remitting multiple sclerosis patients before and after percutaneous transluminal angioplasty: a preliminary report

Concetta De Pasquale,1,2 Maria Luisa Pistorio,1 Massimiliano Veroux,2 Alessia Giaquinta,2 Pierfrancesco Veroux,2 Michele Fornaro11Department of Education Science, University of Catania, Catania, Italy; 2Vascular Surgery and Organ Transplant Unit, Department of Surgery Transplantation and Advanced T...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	De Pasquale C, Pistorio ML, Veroux M, Giaquinta A, Veroux P, Fornaro M
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2014
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/56cc90e258b04742b4e0af9f887d9269
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

EVALUATION OF MAIN INDEXES OF IMMUNE STATE IN THE PATIENTS WITH PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY WITH STENTING
por: O. S. Shkoda, et al.
Publicado: (2016)

Efficacy of percutaneous transluminal renal angioplasty with stent in elderly male patients with atherosclerotic renal artery stenosis
por: Zhao J, et al.
Publicado: (2012)

Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis
por: Lugaresi A, et al.
Publicado: (2013)

Disease-modifying therapies in relapsing&ndash;remitting multiple sclerosis
por: Fabricio Gonz&aacute;lez-Andrade, et al.
Publicado: (2010)

Potential short-term use of oral cladribine in treatment of relapsing-remitting multiple sclerosis
por: Julie A Murphy, et al.
Publicado: (2010)

Author Correction: Systematic evaluation of particle loss during handling in the percutaneous transluminal angioplasty for eight different drug-coated balloons
por: Andreas Heinrich, et al.
Publicado: (2021)

Synchronization within, and interactions between, the default mode and dorsal attention networks in relapsing-remitting multiple sclerosis
por: Huang M, et al.
Publicado: (2018)

Can a physician predict the clinical response to first-line immunomodulatory treatment in relapsing&ndash;remitting multiple sclerosis?
por: Mezei Z, et al.
Publicado: (2012)

Disconnection of the hippocampus and amygdala associated with lesion load in relapsing–remitting multiple sclerosis: a structural and functional connectivity study
por: Zhou F, et al.
Publicado: (2015)

Altered intra- and interregional synchronization in relapsing–remitting multiple sclerosis: a resting-state fMRI study
por: Wu L, et al.
Publicado: (2016)

Functional cortical changes in relapsing-remitting multiple sclerosis at amplitude configuration: a resting-state fMRI study
por: Liu H, et al.
Publicado: (2016)

The Effect of Body Mass Index on Brain Volume and Cognitive Function in Relapsing–Remitting Multiple sclerosis: A CombiRx Secondary Analysis
por: Aliza Bitton Ben-Zacharia, et al.
Publicado: (2021)

Assessing Lumbar Plexus and Sciatic Nerve Damage in Relapsing-Remitting Multiple Sclerosis Using Magnetisation Transfer Ratio
por: Ratthaporn Boonsuth, et al.
Publicado: (2021)

Characteristics, burden of illness, and physical functioning of patients with relapsing-remitting and secondary progressive multiple sclerosis: a cross-sectional US survey
por: Gross HJ, et al.
Publicado: (2017)

Obsessive-compulsive disorder with bipolar diathesis following isotretinoin therapy remitting upon treatment with olanzapine and fluvoxamine
por: Michele Fornaro
Publicado: (2010)

Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis associates with ROS pathway in monocytes
por: Karl E. Carlström, et al.
Publicado: (2019)

Blood-brain barrier permeability of normal appearing white matter in relapsing-remitting multiple sclerosis.
por: Henrik Lund, et al.
Publicado: (2013)

Secondary progressive and relapsing remitting multiple sclerosis leads to motor-related decreased anatomical connectivity.
por: Mark Lyksborg, et al.
Publicado: (2014)

Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis.
por: Anne Waschbisch, et al.
Publicado: (2011)

CELLULAR IMMUNITY PARAMETERS IN PATIENTS WITH REMITTING MULTIPLE SCLEROSIS
por: I. P. Ivanova, et al.
Publicado: (2021)

A CD8+ NK cell transcriptomic signature associated with clinical outcome in relapsing remitting multiple sclerosis
por: Eoin F. McKinney, et al.
Publicado: (2021)

Peripheral neural blockade for pain control in patients undergoing percutaneous angioplasty for complex infrapopliteal disease
por: Abdulrahman Naser, et al.
Publicado: (2021)

Promising Effects of Vitex Agnus-Castus on Quality of Life and Sexual Function in Premenopausal Relapsing Remitting Multiple Sclerosis Patients
por: Sara Rahgooy, et al.
Publicado: (2020)

Circulating miRNAs as Potential Biomarkers Distinguishing Relapsing–Remitting from Secondary Progressive Multiple Sclerosis. A Review
por: Sylwia Pietrasik, et al.
Publicado: (2021)

Pharmacokinetics of daclizumab high-yield process with repeated administration of the clinical subcutaneous regimen in patients with relapsing-remitting multiple sclerosis
por: Tran JQ, et al.
Publicado: (2016)

Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls.
por: Andreas Keller, et al.
Publicado: (2009)

Immune responses against Helicobacter pylori-specific antigens differentiate relapsing remitting from secondary progressive multiple sclerosis
por: Georgios Efthymiou, et al.
Publicado: (2017)

Calcified Lesion Assessment and Intervention in Complex Percutaneous Coronary Intervention: Overview of Angioplasty, Atherectomy, and Lithotripsy
por: Alexander G Truesdell, et al.
Publicado: (2020)

A systematic review of relapse rates during pregnancy and postpartum in patients with relapsing multiple sclerosis
por: Kerstin Hellwig, et al.
Publicado: (2021)

Remitting long-standing major depression in a multiple sclerosis patient with several concurrent conditions
por: Sachinvala ND, et al.
Publicado: (2018)

Intractable and highly active relapsing multiple sclerosis – role of alemtuzumab
por: Dubey D, et al.
Publicado: (2015)

Impact of disease-modifying therapies on MRI and neurocognitive outcomes in relapsing–remitting multiple sclerosis: a protocol for a systematic review and network meta-analysis
por: Christopher Oldmeadow, et al.
Publicado: (2021)

Glutathione Infusion Before and 3 Days After Primary Angioplasty Blunts Ongoing NOX2‐Mediated Inflammatory Response
por: Gaetano Tanzilli, et al.
Publicado: (2021)

Subcutaneous interferon β-1a may protect against cognitive impairment in patients with relapsing-remitting multiple sclerosis: 5-year follow-up of the COGIMUS study.
por: Francesco Patti, et al.
Publicado: (2013)

Balloon Pulmonary Angioplasty: State of the Art
por: John G Coghlan, et al.
Publicado: (2021)

Our experience of robotic coronary angioplasty
por: Vijayachandra Y Reddy, et al.
Publicado: (2021)

A preliminary study on percutaneous transhepatic drainage combined with sequential percutaneous nephroscopy in treatment of refractory liver abscess
por: DUAN Changhu
Publicado: (2021)

Effect of prasugrel versus ticagrelor on coronary microperfusion in ST elevation myocardial infarction patients undergoing percutaneous coronary angioplasty - Acute and short term results
por: Rupesh Santosh Agrawal, et al.
Publicado: (2021)

The impact of endothelial progenitor cells on restenosis after percutaneous angioplasty of hemodialysis vascular access.
por: Chih-Cheng Wu, et al.
Publicado: (2014)

Adjunctive agomelatine therapy in the treatment of acute bipolar II depression: a preliminary open label study
por: Fornaro M, et al.
Publicado: (2013)